Respir Case Rep. 2022; 11(2): 112-115 | DOI: 10.5505/respircase.2022.32704

Atipik Post-COVID Sekeli: Bronþektazi

Emine Afþin
Bolu Abant Ýzzet Baysal Üniversitesi Ýzzet Baysal Eðitim ve Araþtýrma Hastanesi, Bolu

Post- COVID pulmoner fibrozis ve tromboemboli geliþimine dair çok sayýda yayýn olmasýna raðmen, bronþektazi geliþimi ile ilgili literatürde sýnýrlý sayýda yayýn ve olgu sunumlarý bulunmaktadýr. Biz de bu çalýþmamýzda post-COVID 11. ayda bronþektazi sekeli saptanan olgumuzu sunmayý amaçladýk. Kýrk dokuz yaþýnda, erkek, diabetes mellitus ve hipertansi-yon tanýlý, non-smoker hasta, efor dispnesi ile baþ-vurdu. On bir ay önce aðýr COVID-19 pnömonisi ve solunum yetmezliði ile hastanede 1,5 ay süreyle yatý-rýlarak izlenmiþti. Favipiravir, pulse metilprednizolon ve geniþ spekturumlu antibiyotik verilen hastanýn invazif mekanik ventilatör ihtiyacý olmamýþtý ve sekon-der bakteriyel enfeksiyon saptanmamýþtý. Toraks BT‘sinde eski BT’leri ile kýyaslandýðýnda fibrotik deði-þiklikler kaybolmasýna raðmen bronþektazisinin sebat ettiði görüldü. Gelecek yýllarda bronþektazi etyoloji-sinde ilk sorgulayacaðýmýz nedenlerden biri COVID-19 geçirme öyküsü olabilir.

Anahtar Kelimeler: COVID- 19, bronþiektazi, post-COVID sekeli

---

Atypical Post-COVID Sequel: Bronchiectasis

Emine Afþin
Bolu Abant Ýzzet Baysal University Ýzzet Baysal Training and Re-search Hospital, Bolu, Türkiye

Although there have been many studies determining the occurrence of post-COVID pulmonary fibrosis and thromboembolism, there are a limited number of studies and case reports in literature on the develop-ment of bronchiectasis. The present study presents a case of bronchiectasis sequel in the post-COVID 11th month. A 49-year-old male, non-smoker with diabe-tes mellitus and hypertension was admitted with exer-tional dyspnea. The patient had been followed up in the hospital 11 months earlier for 1.5 months with severe COVID-19 pneumonia and respiratory failure for which he was treated with Favipiravir, pulse methylprednisolone and broad-spectrum antibiotics. There was no need for invasive mechanical ventila-tion, and no secondary bacterial infection was de-tected. Compared to the previous CT, a chest CT revealed that bronchiectasis had persisted despite the disappearance of fibrotic changes. In the coming years, one of the first questions raised regarding the etiology of bronchiectasis may be the patient’s COVID-19 history.

Keywords: COVID- 19, bronchiectasis, post-COVID sequel

---

---

ATIF KOPYALA